Publications by authors named "Jun Osugi"

Claim this Profile
U
Uniportal Thoracoscopic Bisegmentectomy of Medial and Posterior Basal Segment (S7+S10).
Yue Cong, Masaaki Nagano, Kosuke Fujishima, Jun Osugi, Koichi Fujiu

Ann Thorac Surg Short Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.
Satoshi Muto, Akio Enta, Yoshiyuki Maruya, Sho Inomata, Hikaru Yamaguchi, Jun Osugi

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer].
Satoshi Muto, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Jun Osugi

Gan To Kagaku Ryoho· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors].
Satoshi Muto, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Jun Osugi

Gan To Kagaku Ryoho· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
Mitsuro Fukuhara, Satoshi Muto, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Jun Osugi

Cancer Immunol Immunother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.
Satoshi Muto, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Jun Osugi

Anticancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).
Hironori Takagi, Songji Zhao, Satoshi Muto, Hiroshi Yokouchi, Hiroshi Nishihara, Jun Osugi

Lung Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.
Satoshi Muto, Yuki Ozaki, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Jun Osugi

Oncol Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Monitoring Tumor Infiltrating Lymphocytes by Peripheral Blood in Lung Cancer Patients].
Satoshi Muto, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Jun Osugi

Gan To Kagaku Ryoho· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma.
Takumi Yamaura, Satoshi Muto, Hayato Mine, Hironori Takagi, Masayuki Watanabe, Jun Osugi

Oncol Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination.
Kazuyoshi Takeda, Kazutaka Kitaura, Ryuji Suzuki, Yuki Owada, Satoshi Muto, Jun Osugi

Cancer Immunol Immunother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.
Mitsunori Higuchi, Hironori Takagi, Yuki Ozaki, Takuya Inoue, Yuzuru Watanabe, Jun Osugi

Fukushima J Med Sci· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Takumi Yamaura, Junji Ezaki, Naoyuki Okabe, Hironori Takagi, Yuki Ozaki, Jun Osugi

Oncol Lett· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
Yuki Matsumura, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Takumi Yamaura, Jun Osugi

Interact Cardiovasc Thorac Surg· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
Takuya Inoue, Hironori Takagi, Yuki Owada, Yuzuru Watanabe, Takumi Yamaura, Jun Osugi

Trials· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients.
Satoshi Muto, Hironori Takagi, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Jun Osugi

Anticancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons.
Mitsunori Higuchi, Hironori Takagi, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Jun Osugi

Oncol Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Jun Osugi, Satoshi Muto, Yuki Matsumura, Mitsunori Higuchi, Hiroyuki Suzuki

J Cancer Res Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor gene mutation as risk factor for recurrence in patients with surgically resected lung adenocarcinoma: a matched-pair analysis.
Yuki Matsumura, Yuki Owada, Takumi Yamaura, Satoshi Muto, Jun Osugi

Interact Cardiovasc Thorac Surg· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report.
Jun Osugi, Yuki Owada, Takumi Yamaura, Satoshi Muto, Naoyuki Okabe

Case Rep Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
Satoshi Muto, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Takumi Yamaura, Jun Osugi

Int J Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Jun Osugi, Takumi Yamaura, Satoshi Muto, Naoyuki Okabe, Yuki Matsumura

Lung Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Naoyuki Okabe, Junji Ezaki, Takumi Yamaura, Satoshi Muto, Jun Osugi

Int J Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.
Jun Osugi, Yuka Kimura, Yuki Owada, Takuya Inoue, Yuzuru Watanabe

J Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of peripheral and local forkhead box P3 regulatory T cells in patients with non-small-cell lung cancer.
Takeo Hasegawa, Hiroyuki Suzuki, Takumi Yamaura, Satoshi Muto, Naoyuki Okabe, Jun Osugi

Mol Clin Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis